A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.
Author: BENJAMIN MUELLER
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says